Interaction of Prion Peptides with DNA Structures

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• Prion protein (PrP) aggregation is implicated in neurodegenerative diseases.
• Macromolecules, including nucleic acids, are known to modulate PrP aggregation.

Purpose of the Study:

• To investigate the interaction between nucleic acids and a synthetic prion protein model peptide (PrP).
• To assess the impact of this interaction on PrP aggregation and cytotoxicity.

Main Methods:

• Utilized synthetic DNA lattices and salmon DNA (sDNA) bound with PrP.
• Employed atomic force microscopy (AFM) for visualization.
• Conducted UV-Vis, CD, and FTIR spectroscopies to analyze molecular interactions and secondary structures.
• Assessed cytotoxicity using human neuroblastoma cells.

Main Results:

• PrP inhibited the growth of DNA lattices.
• Spectroscopic analyses confirmed PrP-DNA interactions and alterations in secondary structures.
• PrP-sDNA complexes exhibited reduced cytotoxicity compared to control peptide-DNA complexes.

Conclusions:

• DNA interaction beneficially modulates pathological prion protein.
• This interaction offers potential therapeutic applications for prion diseases.
• Provides a basis for studying DNA interactions with other amyloidogenic proteins.